Social Media Ideas for Legal & Regulatory And Reimbursement

Regulatory Scrutiny in ABA: What Providers Need to Know About Compliance Oversight

Regulatory Landmines in Health Care Litigation: PHI, Kickback, and Corporate Structure Risks [Video]

The 340B Squeeze: Academic Medical Centers and Large Health Systems Have the Most to Lose

Three federal pricing changes are about to land on a single outpatient claim. The largest infusion and oncology programs will feel them first, and hardest. Most of the 340B debate...

5-Steps to Prepare for CMS’s 2027 Insidious Campaign to Cut Orthopedic and Spine Reimbursement

Red Alert. CMS is cutting reimbursement for orthopedic and spine surgeries. Details are in the fine print.

340B Rebate Pilot — The Clock Starts Now

GLOBE and MFN Pricing: Implications for Cross-Border Drug Development and Transactions

On Oct. 2, 2026, the Centers for Medicare & Medicaid Services (CMS) published the final rule for the Global Benchmark for Efficient Drug Pricing (GLOBE) Model. GLOBE is a manda...

The Medical Device Launch Playbook: Patents, FDA, Reimbursement and Strategic Timing

Bringing a medical device to market requires companies to navigate patent protection, FDA requirements, reimbursement, quality systems and commercialization planning, often at the...

No Surprises Act IDR Portal Overhaul: Key Changes for Providers and Payers

No Surprises Act Enters a New Phase: What Employers and Group Health Plans Need to Know About the 2026 IDR Rules

Highlights New Independent Dispute Resolution (IDR) procedures are taking effect. The 2026 regulations standardize claim communications, restructure open negotiation, clarify b...

Time to Stop “Calling it Reimbursement”

By JEFF GOLDSMITH Back during the Jurassic period, at the beginning of my consulting career, senior colleagues at Ernst and Whinney took me to lunch to explain to the newby the fac...

Medicare, Medicaid, and Reverification: What Patient Support Programs Need to Know Before January 2027

Today's guest post comes from Bryce Aronson, Director of Business Development at AssistRx. Bryce covers three considerations taking effect in January 2027—the end of Medicare P...

DOJ Corporate Fraud Enforcement Memo: What Health Care Companies Need to Know Now

Black Book Releases 2027 Healthcare Policy Outlook Ahead of Medicare Payment Changes

Complimentary report connects reimbursement shifts, Medicaid renewals, $50 billion in rural transformation funding and digital requirements with provider and payer preparedness.

BCBSIL’s New Downcoding Policy Raises Reimbursement Concerns Ahead of New Illinois Restrictions

More Than a Billing Requirement: CMS Turns Medicare Enrollment into a Program-Integrity Tool

Key Updates CMS has proposed a significant expansion of its Medicare provider enrollment and program-integrity authorities through the Calendar Year 2027 Home Health Prospective P...

From Static Content to Living Compliance: The Next Era of Regulated Content in Life Sciences

Every week, commercial and medical affairs teams face an agonizing reality: millions of dollars and hundreds of hours are spent creating regulated content, only for it to stall in...

INFUSE Bone Graft for TLIF receives eligibility for Medicare New Technology Add-on Payment, Advancing Reimbursement Supp...

Medtronic announced that the CMS has granted a New Technology Add-on Payment (NTAP) for INFUSEâ„¢ Bone Graft for TLIF, effective October 1, 2026.

This Week in 340B: September 15 – 21, 2026

Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 3...

<![CDATA[Clarity in Compliance]]>

<![CDATA[Life Sciences Compliance: Diagnosis Incomplete]]>

FDA Medical Devices: Important Regulatory Considerations for Companies Seeking to Enter the U.S. Market

The medical device market in the U.S. is very large and attractive to many companies who are located outside of the U.S. Entering the U.S. medical device market requires a comprehe...

Unlawful Co-Pay Subsidy Scheme – Dompe US Inc. 32M FCA Settlement

ACCESS to Better Care- Things to Know About CMS’s ACCESS Innovation Model

EHR Access Governance Checklist for External RCM and Billing Teams

The following is a guest article by Arun Anandhan, InfoHub Consultancy Services Most conversations about outside billing help start with workload. The billing team is behind, AR is...